The likelihood of contracting the coronavirus appears to be higher among e-cigarette users. This was reported by Elena Samyshina, chief physician of the Moscow Health Department's Third City Comprehensive Clinic and member of Moscow City Duma's Economic and Social Policy Committee.
The deputy used scientific research results to demonstrate that smoking can weaken the body's immunity to the coronavirus.
According to Elena Samyshina, experiments conducted by biologists demonstrate that certain substances in e-cigarettes make cells more susceptible to viral infections.
Scientists connected electronic cigarettes and liquids from various brands to a specialized device that produces vapor at the same concentration levels typically inhaled by humans. They then used the resulting vapor to treat cells and monitored their reaction to modeling SARS-CoV-2 particles. This progress was discussed by the legislator.
Samyshina added that both smokers and doctors should take into account this particular characteristic of the body.
Meanwhile, the incidence of COVID-19 continues to rise. According to the headquarters of the COVID-19 Control Action, Russia recorded 37,067 new cases of coronavirus in the past 24 hours. 4,673 people have been hospitalized, an increase of 135% from the previous day.
In the past 24 hours, 4,405 people in Moscow have been diagnosed with coronavirus.
Statement: 1. This article's content is compiled from third-party information and is only intended for industry exchanges and learning. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The compilation of this article is only used for industry exchange and research. 3. Due to the limitations of the compilation level, the compiled article may not express the same as the original text, please refer to the original text. 4. Regarding any statements and positions related to domestic, Hong Kong, Macao, Taiwan, and foreign affairs, 2FIRSTS fully conforms to the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to delete.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
